FDA clears Abbott’s phone-based glucose monitoring appSeptember 11, 2021
FreeStyle Libre 2 iOS application for use with compatible iPhones has been granted approval by US FDA for integrated continuous glucose monitoring (iCGM) system, Abbott said.
Approved for adults and children (4 and older) with diabetes, the new Libre 2 app creates a seamless experience for users and healthcare professionals. The app enables users to get glucose readings directly on their iPhones without the use of a reader.
A key benefit of the app is the ability for caregivers to remotely mo
Keep reading with one of these options: